KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Eli Lilly (LLY) Enterprise Value (2016 - 2025)

Eli Lilly's Enterprise Value history spans 17 years, with the latest figure at -$7.3 billion for Q4 2025.

  • For Q4 2025, Enterprise Value fell 117.39% year-over-year to -$7.3 billion; the TTM value through Dec 2025 reached -$7.3 billion, down 117.39%, while the annual FY2025 figure was -$7.3 billion, 117.39% down from the prior year.
  • Enterprise Value reached -$7.3 billion in Q4 2025 per LLY's latest filing, up from -$9.9 billion in the prior quarter.
  • In the past five years, Enterprise Value ranged from a high of -$2.1 billion in Q4 2022 to a low of -$9.9 billion in Q3 2025.
  • Average Enterprise Value over 5 years is -$3.5 billion, with a median of -$3.1 billion recorded in 2021.
  • Peak YoY movement for Enterprise Value: surged 44.11% in 2022, then plummeted 186.7% in 2025.
  • A 5-year view of Enterprise Value shows it stood at -$3.7 billion in 2021, then soared by 44.11% to -$2.1 billion in 2022, then tumbled by 35.94% to -$2.8 billion in 2023, then dropped by 17.89% to -$3.3 billion in 2024, then crashed by 117.39% to -$7.3 billion in 2025.
  • Per Business Quant, the three most recent readings for LLY's Enterprise Value are -$7.3 billion (Q4 2025), -$9.9 billion (Q3 2025), and -$3.5 billion (Q2 2025).